Back

Mortality rate of percutaneous coronary interventions in st-segment elevation myocardial infarction patients under the public health insurance schemes of thailand

31 August 2024 (18:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Mapping cardiovascular health: risk factors, interventions, and geographic insights Health Policy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Suppavit Chumsantivut

Bangkok (Thailand)

4 More presentations in this session

Presentation thumbnail
Cardiovascular risk factors and disease mortality among asian american subgroups
Doctor R. Aggarwal (Boston, US)
Abstract Slides Video
Presentation thumbnail
Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis
Associate Professor A. Nelson (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Air pollution and cerebrovascular diseases - retrospective analysis of 10,486 cases of acute ischemic stroke requiring intravenous thrombolysis. A report from the EP-PARTICLES study
Mr M. Swieczkowski (Bialystok, PL)
Abstract Slides Video
Presentation thumbnail
Analyzing the economic ramifications of the broad implementation of generic prasugrel
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Mapping cardiovascular health: risk factors, interventions, and geographic insights

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
5-year mortality after ST-segment elevation myocardial infarction compared to the general population
thumbnail
Congress Session
Determinants of outcome following different coronary revascularisation approaches
thumbnail
Congress Presentation
Long-term outcomes of patients with late presentation STEMI undergoing percutaneous coronary revascularization.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources